Dihydrodiosgenin inhibits endothelial cell-derived factor VIII and platelet-mediated hepatocellular carcinoma metastasis

References

• Chiba T, Iwama A, Yokosuka O. Cancer stem cells in hepatocellular carcinoma: therapeutic implications based on stem cell biology. Hepatol Res. 2016;46(1):50–57. doi:10.1111/hepr.1254826123821
   PubMed Web of Science ®Google Scholar
• Khorana AA, Francis CW, Culakova E, et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2010;5(3):632–634. doi:10.1111/j.1538-7836.2007.02374.x
   Google Scholar
• Sørensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343(25):1846–1850. doi:10.1056/NEJM20001221343250411117976
   PubMed Web of Science ®Google Scholar
• Minagawa M, Makuuchi M, Takayama T, Ohtomo K. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg. 2001;233(3):379–384.11224626
   PubMed Web of Science ®Google Scholar
• Chen XP, Qiu FZ, Wu ZD, et al. Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma. Ann Surg Oncol. 2006;13(7):940–946. doi:10.1245/ASO.2006.08.00716788755
   PubMed Web of Science ®Google Scholar
• Llovet JM, Bustamante J, Castells C, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 2010;29(1):62–67. doi:10.1002/hep.510290145
   Google Scholar
• Lv WF, Liu KC, Lu D, et al. Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis. Cancer Manag Res. 2018;10:4719–4726. doi:10.2147/CMAR.S16652730410405
   PubMed Web of Science ®Google Scholar
• Vishwanath IP, Zakiah SS, Qi CP, et al. Development and novel therapeutics in hepatocellular carcinoma: a review. Therap Clin Risk Manag. 2016;12:445–455.27042086
   PubMed Web of Science ®Google Scholar
• Mezouar S, Frère C, Darbousset R, et al. Role of platelets in cancer and cancer-associated thrombosis: experimental and clinical evidences. Thromb Res. 2016;139:65–76. doi:10.1016/j.thromres.2016.01.00626916298
   PubMed Web of Science ®Google Scholar
• Zhang W, Dang SY, Hong T, et al. A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor microenvironment. Blood. 2012;120(14):2889–2898. doi:10.1182/blood-2012-04-42520722879538
   PubMed Web of Science ®Google Scholar
• Zhao L, Thorsheim CL, Suzuki A, et al. Phosphatidylinositol transfer protein-α in platelets is inconsequential for thrombosis yet is utilized for tumor metastasis. Nat Commun. 17;8(1):1216. doi:10.1038/s41467-017-01181-429084966
   PubMedGoogle Scholar
• Yan MJ, Jurasz P. The role of platelets in the tumor microenvironment: from solid tumors to leukemia. BBA-Mol Cell Res. 2016;1863(3):392–400.
   PubMed Web of Science ®Google Scholar
• Gay LJ, Feldinghabermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011;11(2):123–134. doi:10.1038/nrc300421258396
   PubMed Web of Science ®Google Scholar
• Franco AT, Corken A, Ware J. Platelets at the interface of thrombosis, inflammation, and cancer. Blood. 2015;126(5):582–588. doi:10.1182/blood-2014-08-53158226109205
   PubMed Web of Science ®Google Scholar
• Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423–1437. doi:10.1038/nm.339424202395
   PubMed Web of Science ®Google Scholar
• Menter DG, Tucker SC, Kopetz S, Sood AK, Crissman JD, Honn KV. Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev. 2014;33(1):231–269. doi:10.1007/s10555-014-9498-024696047
   PubMed Web of Science ®Google Scholar
• Lisman T, Luyendyk JP. Platelets as modulators of liver diseases. Semin Thromb Hemost. 2018;44(2):114–125. doi:10.1055/s-0037-160409128898899
   PubMed Web of Science ®Google Scholar
• Carr BI, Cavallini A, D‘Alessandro R. Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro. BMC Cancer. 2014;14:43.24468103
   PubMed Web of Science ®Google Scholar
• Zhang R, Guo H, Xu J, et al. Activated platelets inhibit hepatocellular carcinoma cell differentiation and promote tumor progression via platelet-tumor cell binding. Oncotarget. 2016;7(37):60609–60622. doi:10.18632/oncotarget.1130027542264
   PubMedGoogle Scholar
• Gong N, Chatterjee S. Platelet endothelial cell adhesion molecule in cell signaling and thrombosis. Mol Cell Biochem. 2003;253(1–2):151–158.14619965
   PubMed Web of Science ®Google Scholar
• Jacquemin M, Neyrinck A, Hermanns MI, et al. FVIII production by human lung microvascular endothelial cells. Blood. 2006;108(2):515–17. doi:10.1182/blood-2005-11-457116569771
   PubMed Web of Science ®Google Scholar
• Van den Biggelaar M, Bouwens EAM, Kootstra NA, et al. Storage and regulated secretion of factor VIII in blood outgrowth endothelial cells. Haematologica. 2009;94(5):670–678. doi:10.3324/haematol.1342719336741
   PubMed Web of Science ®Google Scholar
• Yigit E, Gönüllü G, Yücel İ, et al. Relation between hemostatic parameters and prognostic/predictive factors in breast cancer. Eur J Intern Med. 2008;19(8):602–607. doi:10.1016/j.ejim.2007.06.03619046726
   PubMed Web of Science ®Google Scholar
• Auwerda JJA, Pieter S, De Maat MPM, et al. Prothrombotic coagulation abnormalities in patients with newly diagnosed multiple myeloma. Haematologica. 2007;92(2):279–280.17296591
   PubMed Web of Science ®Google Scholar
• Van Beijnum JR, Rousch M, Castermans K, van der Linden E, Griffioen AW. Isolation of endothelial cells from fresh tissues. Nat Protoc. 2008;3(6):1085–1091.18546599
   PubMed Web of Science ®Google Scholar
• Chouaib S, Kieda C, Benlalam H, Noman MZ, Mami-Chouaib F, Rüegg C. Endothelial cells as key determinants of the tumor microenvironment: interaction with tumor cells, extracellular matrix and immune killer cells. Crit Rev Immunol. 2010;30(6):529–545.21175416
   PubMed Web of Science ®Google Scholar
• Franses JW, Baker AB, Chitalia VC, Edelman ER. Stromal endothelial cells directly influence cancer progression. Sci Transl Med. 2011;3(66):66ra5. doi:10.1126/scitranslmed.3001542
   PubMed Web of Science ®Google Scholar
• Zervantonakis IK, Hughesalford SK, Charest JL, Condeelis JS, Gertler FB, Kamm RD. Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function. Proc Natl Acad Sci USA. 2012;109(34):13515–13520. doi:10.1073/pnas.121018210922869695
   PubMed Web of Science ®Google Scholar
• Jung DH, Park HJ, Byun HE, et al. Diosgenin inhibits macrophage-derived inflammatory mediators through downregulation of CK2, JNK, NF-κB and AP-1 activation. Int Immunopharmacol. 2010;10(9):1047–1054. doi:10.1016/j.intimp.2010.06.00420601188
   PubMed Web of Science ®Google Scholar
• He Z, Chen H, Li G, et al. Diosgenin inhibits the migration of human breast cancer MDA-MB-231 cells by suppressing Vav2 activity. Phytomedicine. 2014;21(6):871–876. doi:10.1016/j.phymed.2014.02.00224656238
   PubMed Web of Science ®Google Scholar
• Yang HP, Yue L, Jiang WW, Liu Q, Kou J-P, Yu B-Y. Diosgenin inhibits tumor necrosis factor-induced tissue factor activity and expression in THP-1 cells via down-regulation of the NF-κB, Akt, and MAPK signaling pathways. Chin J Nat Med. 2013;11(6):608–6015. doi:10.1016/S1875-5364(13)60070-924345501
   PubMed Web of Science ®Google Scholar
• Ma HD, Deng YR, Tian Z, Lian Z-X. Traditional Chinese medicine and immune regulation. Clin Rev Allergy Immunol. 2013;44(3):229–241. doi:10.1007/s12016-012-8332-022826112
   PubMed Web of Science ®Google Scholar
• Chen Y, Tang YM, Yu SL, et al. Advances in the pharmacological activities and mechanisms of diosgenin. Chin J Nat Med. 2015;13(8):578–587. doi:10.1016/S1875-5364(15)30053-426253490
   PubMed Web of Science ®Google Scholar
• Li YJ, Wang XR, Chen S, et al. Diosgenin induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma cells. Oncol Rep. 2015;33(2):693–698. doi:10.3892/or.2014.362925434486
   PubMed Web of Science ®Google Scholar
• Kim DS, Jeon BK, Lee YE, et al. Diosgenin induces apoptosis in HepG2 cells through generation of reactive oxygen species and mitochondrial pathway. Evid-Based Compl Alt. 2012;2012:981675.
   PubMed Web of Science ®Google Scholar
• Zheng H, Wei Z, Xin G, et al. Preventive effect of a novel diosgenin derivative on arterial and venous thrombosis in vivo. Bioorg Med Chem Lett. 2016;26(14):3364–3369. doi:10.1016/j.bmcl.2016.05.03227217000
   PubMed Web of Science ®Google Scholar
• Wei Z, Xin G, Wang H, et al. The diosgenin prodrug nanoparticles with pH-responsive as a drug delivery system uniquely prevents thrombosis without increased bleeding risk. Nanomedicine. 2018;14(3):637–684.
   Web of Science ®Google Scholar
• Gong G, Qin Y, Huang W. Anti-thrombosis effect of diosgenin extract from Dioscorea zingiberensis C.H. Wright in vitro and in vivo. Phytomedicine. 2011;18(6):458–463. doi:10.1016/j.phymed.2010.08.01521036572
   PubMed Web of Science ®Google Scholar
• Fueyo MCD, Dansey MV, Paolo LS, Pecci A, Veleiro AS, Burton G. C(16)-C(22) oxygen-bridged analogues of ce DAF-12 and LXR ligands. Steroids. 2016;112:109–114. doi:10.1016/j.steroids.2016.05.00927235856
   PubMed Web of Science ®Google Scholar
• Kim HS, Kim MJ, Kim EJ, Yang Y, Lee M-S, Lim J-S. Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression. Biochem Pharmacol. 2012;83(3):385–394. doi:10.1016/j.bcp.2011.11.00822120676
   PubMed Web of Science ®Google Scholar
• Kamiyama M, Shirai T, Tamura S, et al. ASK1 facilitates tumor metastasis through phosphorylation of an ADP receptor P2Y12 in platelets. Cell Death Differ. 17;24(12):2066–2076. doi:10.1038/cdd.2017.11428753204
   PubMed Web of Science ®Google Scholar
• Johnson KE, Forward JA, Tippy MD, et al. Tamoxifen directly inhibits platelet angiogenic potential and platelet-mediated metastasis. Arterioscler Thromb Vasc Biol. 17;37(4):664–674. doi:10.1161/ATVBAHA.116.30879128153880
   PubMed Web of Science ®Google Scholar
• Ma L, Yao X, Wei Z, et al. Deoxyarbutin displays antitumour activity against melanoma in vitro and in vivo through a p38-mediated mitochondria associated apoptotic pathway. Sci Rep. 17;7:1.28127051
   PubMed Web of Science ®Google Scholar
• Broze GJ, Yin ZF, Lasky N. A tail vein bleeding time model and delayed bleeding in hemophiliac mice. Thromb Haemost. 2001;86(04):747–748.
   Google Scholar
• Zhang R, Huang B, Du D, et al. Anti-thrombosis effect of diosgenyl saponins in vitro and in vivo. Steroids. 2013;78(11):1064–1070. doi:10.1016/j.steroids.2013.07.00323891646
   PubMed Web of Science ®Google Scholar
• Kilkenny C, Browne WJ, Cuthill IC, et al. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2014;4(1):e1000412.
   Google Scholar
• Ward Y, Lake R, Faraji F, et al. Platelets promote metastasis via binding tumor CD97 leading to bidirectional signaling that coordinates transendothelial migration. Cell Rep. 2018;23(3):808–822.29669286
   PubMed Web of Science ®Google Scholar
• Labelle M, Hynes RO. The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov. 2012;2(12):1091–1099. doi:10.1158/2159-8290.CD-12-032923166151
   PubMed Web of Science ®Google Scholar
• Möhle R, Green D, Moore MA, Nachman RL, Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA. 1997;94(2):663–668.9012841
   PubMed Web of Science ®Google Scholar
• Myriam L, Shahinoor B, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20(5):576–590. doi:10.1016/j.ccr.2011.09.00922094253
   PubMed Web of Science ®Google Scholar
• Machlus KR, Feng-Chang L, Wolberg AS. Procoagulant activity induced by vascular injury determines contribution of elevated factor VIII to thrombosis and thrombus stability in mice. Blood. 2011;118(14):3960–3968. doi:10.1182/blood-2011-06-36281421828144
   PubMed Web of Science ®Google Scholar
• Hollestelle MJ, Geertzen HGM, Straatsburg IH, van Gulik TM, van Mourik JA. Factor VIII expression in liver disease. Thromb Haemost. 2004;91(2):267–275. doi:10.1160/TH03-05-031014961153
   PubMed Web of Science ®Google Scholar
• Chen PS, Shis YW, Huang HC, Cheng H-W, Means RE. Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression. PLoS One. 2011;6(5):e20164. doi:10.1371/journal.pone.002016421629786
   PubMed Web of Science ®Google Scholar
• Goel A, Chang DK, Ricciardiello L, Gasche C, Boland CR. A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells. Clin Cancer Res. 2003;9(1):383–390.12538492
   PubMed Web of Science ®Google Scholar
• Italiano JE, Richardson JL, Sunita PH, et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood. 2008;111(3):1227–1233. doi:10.1182/blood-2007-09-11383717962514
   PubMed Web of Science ®Google Scholar
• Haemmerle M, Stone RL, Menter DG, Afshar-Kharghan V, Sood AK. The platelet lifeline to cancer: challenges and opportunities. Cancer Cell. 2018;33(6):965–983. doi:10.1016/j.ccell.2018.03.00229657130
   PubMed Web of Science ®Google Scholar
• Schumacher D, Strilic B, Sivaraj KK, Wettschureck N, Offermanns S. Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor. Cancer Cell. 2013;24(1):130–137. doi:10.1016/j.ccr.2013.05.00823810565
   PubMed Web of Science ®Google Scholar
• Creighton CJ, Gibbons DL, Kurie JM. The role of epithelial- mesenchymal transition programming in invasion and metastasis: a clinical perspective. Cancer Manag Res. 2013;5:187–195. doi:10.2147/CMAR.S3517123986650
   PubMedGoogle Scholar
• Storb R, Marchioro TL, Graham TC, Willemin M, Hougie C, Thomas ED. Canine hemophilia and hemopoietic grafting. Blood. 1972;40(2):234–238.4557986
   PubMed Web of Science ®Google Scholar
• Lima LG, Monteiro RQ. Activation of blood coagulation in cancer: implications for tumour progression. Biosci Rep. 2013;33(5):e00064. doi:10.1042/BSR2013005723889169
   PubMedGoogle Scholar
• Im JH, Fu WH, Bhatia SK, et al. Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res. 2004;64(23):8613–8619. doi:10.1158/0008-5472.CAN-04-207815574768
   PubMed Web of Science ®Google Scholar